Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prudential Jennison Health Sciences Fund Class B (PHLBX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund seeks investments whose price will increase over time. It normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector- such as pharmaceutical companies- biotechnology companies- medical device manufacturers- healthcare service providers and health maintenance organizations (HMOs) and other companies that derive at least 50% of their assets- revenues or profits from operations in the healthcare sector. The fund is non-diversified.


1 month+6.41% 3 years+5.00%
3 months+5.70% 5 years+18.64%
1 year+27.96% Since inception+14.68%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return+18.64%+17.28%
Expense ratio1.87%1.32%
Risk 5 year sharpe ratio0.941.11
Net assets$2.3B$3.0B
Average market cap$12.0B$9.3B
Average P/E--21.7
Portfolio turnover25%25%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Funds (PGIM Investments)
Fund manager & tenureDavid Chan / 18 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00


U.S. stock93.82%
International stock2.51%
Fixed income0.35%
Top 5 Sectors
Portfolio weighting
Healthcare 97.95%
Consumer service 1.34%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
UNH UnitedHealth7.39%
BMRN Biomarin Pharmaceutical Inc5.48%
HUM Humana Inc4.05%
CI Cigna Corp3.60%
AERI Aerie Pharmaceuticals Inc3.57%
BLUE bluebird bio Inc3.53%
ASMB Assembly Biosciences Inc3.44%
ILMN Illumina Inc3.35%
AGN Allergan3.29%
AET Aetna2.77%